VOLUNTEER FOR RESEARCH
WHIM Study: CBD for Endometriosis
Clinical Trial
BAcKGROUND
Despite the proliferation of cannabis and cannabinoid products in recent years, little research has been done to determine the impact of these products on womens health conditions, including endometriosis. This study is designed to assess the impact of a custom-formulated, hemp-derived, full-spectrum, high-CBD product vs. placebo on clinical symptoms and biomarkers over the course of 12 weeks of treatment in patients with endometriosis. This project will provide information that does not currently exist on the potential efficacy of a cannabinoid-based sublingual product for endometriosis.
STUDY DETAILS
This study is a double-blind crossover clinical trial of a high-CBD product compared to placebo over a total of 12 weeks of treatment in patients with endometriosis. Participants will complete 7 visits over 12 weeks; 4 visits will be conducted in-person at McLean Hospital in Belmont, MA, and 3 visits will be conducted remotely. Visits consist of clinical ratings, assessments of conventional medication use, quality of life measures, and providing saliva, urine, and blood samples.
Visit https://clinicaltrials.gov/study/NCT06477406 for more info
RECRUITMENT INFORMATION
Individuals living with endometriosis who are interested in trying a cannabinoid-based sublingual product for treating endometriosis symptoms, including pain, gastrointestinal issues, and mood/anxiety
We are not yet recruiting for this study. If you're interested in participating please send us an email at cbdstudy@mclean.harvard.edu and we'll reach out to you when enrollment opens.